Tokyo, Japan

Masayo Suzuki

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Machida, JP (2011)
  • Tokyo, JP (2009 - 2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Masayo Suzuki: Innovator in Antibody Development

Introduction

Masayo Suzuki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work is paving the way for advancements in medical treatments and diagnostics.

Latest Patents

One of her latest patents involves DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody. This invention aims to provide a monoclonal antibody that is useful for treating or diagnosing diseases related to the ASCT2 transporter. The patent details a monoclonal antibody that specifically recognizes the native three-dimensional structure of the extracellular region of ASCT2. It also includes a hybridoma that produces the antibody, a DNA encoding the antibody, and a vector containing the DNA. Furthermore, it outlines a process for producing the antibody or its fragments, along with therapeutic and diagnostic agents utilizing these antibodies.

Career Highlights

Masayo Suzuki is currently associated with Kyowa Hakko Kirin Co., Limited, where she continues her innovative work in antibody research. Her expertise in this area has led to significant advancements in understanding and treating diseases related to amino acid transporters.

Collaborations

Throughout her career, Masayo has collaborated with notable colleagues, including Hiroshi Ando and Norihiko Shiraishi. These collaborations have further enhanced her research and contributed to the success of her inventions.

Conclusion

Masayo Suzuki's contributions to the field of biotechnology, particularly in the development of monoclonal antibodies, highlight her role as a leading inventor. Her innovative work continues to impact medical science and improve treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…